Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1313021rdf:typepubmed:Citationlld:pubmed
pubmed-article:1313021lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0001898lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0165519lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0079866lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0441633lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:1313021lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:1313021pubmed:issue10lld:pubmed
pubmed-article:1313021pubmed:dateCreated1992-4-28lld:pubmed
pubmed-article:1313021pubmed:abstractTextThe human 72-kDa (CLG4A) and 92-kDa (CLG4B) type IV collagenases contain a domain consisting of three contiguous copies of the fibronectin (FN)-derived type II homology unit (T2HU), T2HU-1, T2HU-2, and T2HU-3. To investigate the functional role of this domain, we have constructed plasmids expressing beta-galactosidase fusion proteins with one or more of the CLG4B-derived T2HU. The gelatin binding assays demonstrate that a single copy of T2HU-2 renders beta-galactosidase capable of binding gelatin. The three repeats, however, differ dramatically in their capacity to bind gelatin, with T2HU-1 and T2HU-3 having significantly less binding activity than T2HU-2. Using alanine scanning mutagenesis we have defined the amino acid residues (Arg307, Asp309, Asn319, Tyr320, Asp323) that are critical for gelatin binding of T2HU-2. The low gelatin binding of T2HU-1 compared to T2HU-2 was traced to the non-conserved residues Ala228-Ala and Leu253-Pro. The results suggest that the gelatin binding of the type IV collagenase proenzyme is mediated by the FN-like domain, although the presence of another gelatin-binding site cannot be excluded. The FN domain-mediated binding, however, is not a rate-limiting step in the hydrolysis of gelatin by the enzyme.lld:pubmed
pubmed-article:1313021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:languageenglld:pubmed
pubmed-article:1313021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:citationSubsetIMlld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1313021pubmed:statusMEDLINElld:pubmed
pubmed-article:1313021pubmed:monthAprlld:pubmed
pubmed-article:1313021pubmed:issn0021-9258lld:pubmed
pubmed-article:1313021pubmed:authorpubmed-author:StronginA YAYlld:pubmed
pubmed-article:1313021pubmed:authorpubmed-author:Birkedal-Hans...lld:pubmed
pubmed-article:1313021pubmed:authorpubmed-author:GoldbergG IGIlld:pubmed
pubmed-article:1313021pubmed:authorpubmed-author:CollierI EIElld:pubmed
pubmed-article:1313021pubmed:authorpubmed-author:KrasnovP APAlld:pubmed
pubmed-article:1313021pubmed:issnTypePrintlld:pubmed
pubmed-article:1313021pubmed:day5lld:pubmed
pubmed-article:1313021pubmed:volume267lld:pubmed
pubmed-article:1313021pubmed:ownerNLMlld:pubmed
pubmed-article:1313021pubmed:authorsCompleteYlld:pubmed
pubmed-article:1313021pubmed:pagination6776-81lld:pubmed
pubmed-article:1313021pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:meshHeadingpubmed-meshheading:1313021-...lld:pubmed
pubmed-article:1313021pubmed:year1992lld:pubmed
pubmed-article:1313021pubmed:articleTitleAlanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase.lld:pubmed
pubmed-article:1313021pubmed:affiliationDivision of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110.lld:pubmed
pubmed-article:1313021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1313021pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1313021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1313021lld:pubmed